Abstract
Earlier studies showed that administration of MTX to patients leads to an increase in the level of DHFR protein in both normal and leukemic leukocytes as well as in erythrocytes within hours to days.1,2,3 In vitro studies using a human lymphoblastoid cell line showed that increase in DHFR protein is not transcriptionally mediated but was abolished by cycloheximide treatment, suggesting that new protein synthesis is required.4 The rapid increase observed was attributed to either protection of DHFR from degradation by bound MTX and/or dihydrofolate,4 or to an increase in translation of this enzyme.5 An increase in thymidylate synthase activity has been reported after 5-fluorouracil treatment,6–8 and it has been suggested that this increase may also be regulated at the translational level.7,8 In this communication, we show that DHFR protein regulates its synthesis by exerting an inhibitory influence on its translation and that addition of MTX or dihydrofolate to the reticulocyte translation system relieves this inhibition, thus providing a possible explanation for the rapid increase in this enzyme activity noted in certain cells after MTX administration. In addition, preliminary experiments using CHO cells lacking the DHFR gene and transfected with DHFR cDNA lacking the 5′ leader sequence and treated with MTX showed an increase in DHFR, indicating that this region may not be required for the DHFR protein/RNA interaction.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.R. Bertino, D.M. Donohue, B.W. Gabrio, R. Silber, A. Alenty, M.Meyers, and F.M. Huennekens, Increased level of dihydrofolate reductase in leukocytes of patients treated with aminopterin, Nature 193:140–141 (1962).
J.R. Bertino, D.M. Donohue, B. Simmons, B.W. Gabrio, R. Silber, and F.M. Huennekens, The “induction” of dihydrofolate reductase in leukocytes and erythrocytes of patients treated with methotrexate, J. Clin. Invest. 43:466–475 (1963).
J.R. Bertino and B.L. Hillcoat, Regulation of dihydrofolate reductase and other folate requiring enzymes, in: “Advances in Enzyme Regulation,” Pergamon Press, New York (1968).
B.L. Hillcoat, V. Swett, and J.R. Bertino, Increase of dihydrofolate reductase activity in cultured mammalian cells after exposure to methotrexate, Proc. Natl. Acad. Sci., U.S.A. 58:1632–1637 (1967).
K. Bastow, R. Prabhu, and Y.-C. Cheng, The intracellular content of dihydrofolate reductase: possibilities for control and implications for chemotherapy, Adv. Enz. Reg. 22:15–26 (1984).
K.D. Danenberg and P.V. Danenberg, Activity of thymidylate synthase and its inhibition by 5-fluorouracil in highly enzyme-overproducing cells resistant to 10-propargyl-5,8,-dideazafolate, Mol. Pharmacol. 36:219– 223 (1989).
E. Chu, J.C. Drake, D.M. Koeller, S. Zinn, C.A. Jamis-Dow, G.C. Yeh, and C.A. Allegra, Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines, Mol. Pharmacol. 36:136–143 (1990).
E. Chu, D.M. Koeller, J.L. Casey, J.C. Drake, B.A. Chabner, P.C.Elwood, S. Zinn, and C.J. Allegra, Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate, Proc. Natl. Acad. Sci., U.S.A. 88:8977–8981 (1991).
G. Urlaub, E. Kas, A.M. Carothers, and L. Chasin, Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells, Cell 33:405–412 (1983).
B.I. Schweitzer, S. Srimatkandada, H. Gritsman, R. Sheridan, R.Venkataraghavan, and J.R. Bertino, Probing the role of two hydrophobic active site residues in the human dihydrofolate reductase by site directed mutagenesis. J. Biol. Chem. 264:20786–20795 (1989).
K.H. Cowan, M.E. Goldsmith, M.D. Ricciardone, R. Levine, E. Rubalcaba, and J. Jolivet, Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene, Mol. Pharmacol. 30:69–76 (1990).
E.C. Theil, Regulation of ferritin and transferrin receptor mRNAs, J.Biol. Chem. 9:4771–4774 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ercikan, E., Banerjee, D., Waltham, M., Schnieders, B., Scotto, K.W., Bertino, J.R. (1993). Translational Regulation of the Synthesis of Dihydrofolate Reductase. In: Ayling, J.E., Nair, M.G., Baugh, C.M. (eds) Chemistry and Biology of Pteridines and Folates. Advances in Experimental Medicine and Biology, vol 338. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2960-6_109
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2960-6_109
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6287-6
Online ISBN: 978-1-4615-2960-6
eBook Packages: Springer Book Archive